Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Current Assets (2016 - 2025)

Mimedx's Current Assets history spans 15 years, with the latest figure at $277.5 million for Q4 2025.

  • For Q4 2025, Current Assets rose 44.6% year-over-year to $277.5 million; the TTM value through Dec 2025 reached $277.5 million, up 44.6%, while the annual FY2025 figure was $277.5 million, 44.6% up from the prior year.
  • Current Assets for Q4 2025 was $277.5 million at Mimedx, up from $254.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $277.5 million in Q4 2025 and bottomed at $131.0 million in Q2 2022.
  • The 5-year median for Current Assets is $149.2 million (2021), against an average of $166.3 million.
  • The largest annual shift saw Current Assets decreased 17.25% in 2021 before it surged 47.61% in 2025.
  • A 5-year view of Current Assets shows it stood at $148.5 million in 2021, then decreased by 9.64% to $134.2 million in 2022, then grew by 22.4% to $164.3 million in 2023, then grew by 16.82% to $191.9 million in 2024, then soared by 44.6% to $277.5 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Current Assets are $277.5 million (Q4 2025), $254.1 million (Q3 2025), and $220.9 million (Q2 2025).